Search

The three recipients of the 2023 Paul Marks Prize for Cancer Research will present their research at a symposium. Learn about the research of Mark Agnel Frederick Dawson, Cigall Kadoch, and Michelle Monje,

… Monday, March 18, 2024 The three recipients of the 2023  Paul Marks Prize for Cancer Research will present their research at a symposium to be held March 26, 2024. The prize was named in honor of the late  Paul A. Marks, MD , President Emeritus of Memorial Sloan Kettering Cancer Center (MSK). It recognizes

New research looks at how a series of mutations in normal blood cells can lead to them becoming cancerous and how these mutations accumulate as cancer progresses.

… Wednesday, October 28, 2020 Summary The biggest study ever to examine the genetic causes of leukemia at the level of individual cells reveals how a series of mutations in normal blood cells can lead to them eventually becoming cancerous. When Memorial Sloan Kettering postdoctoral fellows Linde Miles

Kieran Healy was feeling worse by the day. A new father at 43 years old, he was bone-tired and losing weight. He had night sweats and a strange lump in his belly. His local hospital in Manhattan ordered an ultrasound and a CT (computed tomography) scan — but they were scheduled over a month away.

… Monday, June 5, 2023 Kieran Healy was feeling worse by the day. A new father at 43 years old, he was bone-tired and losing weight. He had night sweats and a strange lump in his belly. His local hospital in Manhattan ordered an ultrasound and a CT (computed tomography) scan — but they were scheduled over

Data from a recent study on women enrolled in Memorial Sloan Kettering Cancer Center’s high-risk breast cancer surveillance program highlights that a “substantial number” would benefit from interventions to mitigate modifiable risk.

… Wednesday, August 23, 2017 Data from a recent study on women enrolled in Memorial Sloan Kettering Cancer Center’s high-risk breast cancer surveillance program highlights that a “substantial number” would benefit from interventions to further reduce risk, including education on modifiable lifestyle factors

Learn about kratom, an herbal product that some believe acts as a painkiller and could help those with cancer.

… Wednesday, August 8, 2018 Summary MSK experts say we don’t yet have enough information about kratom to know whether it is safe and effective for people with cancer. In the past few years, a number of companies in the United States have begun selling an herbal product called kratom, mostly online. The

A team of scientists is combining sophisticated chemistry and experiments in zebrafish to develop a new cancer drug that shows early potential against melanoma and metastatic breast cancer.

… Monday, June 22, 2015 Summary A growing community of Memorial Sloan Kettering scientists are doing research into  epigenetics  — an intricate system of biochemical adjustments that cells use to regulate genes — to improve our understanding of cancer and other diseases. One of these researchers is Mingkui

A visionary program investigates how the body’s ecosystem affects cancer.

… Friday, April 1, 2022 Dear MSK Community,   We are poised at a pivotal moment in cancer research.   For the past few decades, researchers have focused on identifying gene mutations associated with cancer and have developed highly effective drugs to target them. This revolutionary approach, called precision

Temozolomide chemotherapy reduced seizures in 90 percent of patients with World Health Organization (WHO) grade 2 oligodendroglioma and tumor-related epilepsy.

… Friday, June 28, 2019 Temozolomide chemotherapy reduced seizures in 90 percent of patients with World Health Organization (WHO) grade 2 oligodendroglioma and tumor-related epilepsy, according to the results of a recent retrospective study of 39 patients treated at Memorial Sloan Kettering Cancer Center

Recent research from Memorial Sloan Kettering shows that dual-energy contrast-enhanced digital mammography (CEDM) is as sensitive in detecting breast cancer as contrast-enhanced breast MRI when both were compared with standard mammograms.

… Friday, December 8, 2017 Donna D’Alessio, MD Donna D’Alessio, MD Recent research from Memorial Sloan Kettering shows that dual-energy contrast-enhanced digital mammography (CEDM) is as sensitive in detecting breast cancer as contrast-enhanced breast MRI when both were compared with standard mammograms

Researchers at Memorial Sloan Kettering Cancer Center (MSK), have published the first systemic review of the association between industry payments and physician prescribing in order to determine whether evidence is sufficient to conclude that payments cause physicians to change their prescribing practices across a broad range of  medical specialties and drug types.

… Monday, November 23, 2020 Researchers at Memorial Sloan Kettering Cancer Center (MSK), led by Aaron Mitchell, MD, MPH, a medical oncologist and health services researcher in the  Department of Epidemiology and Biostatistics , have published the first systemic review of the association between industry